Quidel Company Leadership
| QDEL Stock | USD 25.45 1.23 4.61% |
Quidel employs about 6.6 K people. The company is managed by 23 executives with a total tenure of roughly 27 years, averaging almost 1.0 years of service per executive, having 286.96 employees per reported executive. Inspection of Quidel's management performance can provide insight into the company performance.
| Douglas Bryant CEO CEO and President and Director |
Quidel's latest congressional trading
Congressional trading in companies like Quidel, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Quidel by those in governmental positions are based on the same information available to the general public.
| 2021-04-10 | Representative Tom Malinowski | Acquired Under $15K | Verify | ||
| 2021-03-06 | Representative Tom Malinowski | Acquired $15K to $50K | Verify |
Quidel Management Team Effectiveness
The company has return on total asset (ROA) of 0.0112 % which means that it generated a profit of $0.0112 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1138) %, meaning that it created substantial loss on money invested by shareholders. Quidel's management efficiency ratios could be used to measure how well Quidel manages its routine affairs as well as how well it operates its assets and liabilities.Quidel Workforce Comparison
Quidel is rated third in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 41,879. Quidel retains roughly 6,600 in number of employees claiming about 16% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.13) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.07 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.07. Quidel Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Quidel insiders, such as employees or executives, is commonly permitted as long as it does not rely on Quidel's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Quidel insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buechler Kenneth F few days ago Disposition of 9215 shares by Buechler Kenneth F of Quidel at 15.74 subject to Rule 16b-3 | ||
Busky Joseph M. over a month ago Disposition of 5392 shares by Busky Joseph M. of Quidel subject to Rule 16b-3 | ||
Dilsaver Evelyn S over a month ago Acquisition by Dilsaver Evelyn S of 4929 shares of Quidel subject to Rule 16b-3 | ||
Philip McLellan over a month ago Disposition of 420 shares by Philip McLellan of Quidel subject to Rule 16b-3 | ||
Polan Mary Lake Ph D over two months ago Disposition of 128 shares by Polan Mary Lake Ph D of Quidel subject to Rule 16b-3 | ||
Philip McLellan over two months ago Disposition of 1945 shares by Philip McLellan of Quidel subject to Rule 16b-3 | ||
Philip McLellan over two months ago Disposition of 3237 shares by Philip McLellan of Quidel subject to Rule 16b-3 | ||
Michelle Hodges over three months ago Acquisition by Michelle Hodges of 10 shares of Quidel subject to Rule 16b-3 |
Quidel Notable Stakeholders
A Quidel stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Quidel often face trade-offs trying to please all of them. Quidel's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Quidel's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Douglas Bryant | CEO and President and Director | Profile | |
| Brian Blaser | CEO President | Profile | |
| Robert JD | Executive President | Profile | |
| Jonathan Siegrist | Executive CTO | Profile | |
| Michelle Hodges | General VP | Profile | |
| Ruben Argueta | Director Relations | Profile | |
| Juliet Cunningham | Vice Relations | Profile | |
| Michelle JD | Chief Secretary | Profile | |
| Chockalingam Palaniappan | Chief Officer | Profile | |
| Joseph CPA | Chief Officer | Profile | |
| Louise Brandy | Senior Officer | Profile | |
| Tamara Ranalli | Molecular Leader | Profile | |
| Iris Lin | ASPAC Japan | Profile | |
| Phillip Askim | Associate VP | Profile | |
| Patrick Klein | Senior Officer | Profile | |
| Andrew Corkum | Senior LATAM | Profile | |
| Ronald Bowman | Chief Officer | Profile | |
| William Ferenczy | Point Leader | Profile | |
| Philip McLellan | Chief Officer | Profile | |
| Audra Jones | Senior America | Profile | |
| Werner Kroll | Senior Development | Profile | |
| Lisa Hayes | Vice Communications | Profile | |
| Michael Iskra | Executive Officer | Profile |
About Quidel Management Performance
The success or failure of an entity such as Quidel often depends on how effective the management is. Quidel management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Quidel management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Quidel management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company was founded in 1979 and is headquartered in San Diego, California. Quidelortho Corp operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 1600 people.
Quidel Workforce Analysis
Traditionally, organizations such as Quidel use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Quidel within its industry.Quidel Manpower Efficiency
Return on Quidel Manpower
| Revenue Per Employee | 421.7K | |
| Revenue Per Executive | 121M | |
| Net Loss Per Employee | 310.9K | |
| Net Loss Per Executive | 89.2M | |
| Working Capital Per Employee | 33.3K | |
| Working Capital Per Executive | 9.6M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quidel. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Quidel Stock please use our How to buy in Quidel Stock guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quidel. If investors know Quidel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quidel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Quidel is measured differently than its book value, which is the value of Quidel that is recorded on the company's balance sheet. Investors also form their own opinion of Quidel's value that differs from its market value or its book value, called intrinsic value, which is Quidel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quidel's market value can be influenced by many factors that don't directly affect Quidel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quidel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Quidel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quidel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.